Mid-Del Therapeutic Center, Inc. v. Commissioner ( 2002 )


Menu:
  •                                                                           F I L E D
    United States Court of Appeals
    Tenth Circuit
    UNITED STATES COURT OF APPEALS
    FEB 20 2002
    FOR THE TENTH CIRCUIT
    PATRICK FISHER
    Clerk
    MID-DEL THERAPEUTIC
    CENTER, INC.; D. RICHARD
    ISHMAEL, M.D., PC,
    Petitioners-Appellants,
    v.                                                   No. 01-9000
    (T.C. Nos. 9060-97, 9270-97)
    COMMISSIONER OF INTERNAL                         (Petition for Review)
    REVENUE,
    Respondent-Appellee.
    ORDER AND JUDGMENT            *
    Before LUCERO , PORFILIO , and ANDERSON , Circuit Judges.
    After examining the briefs and appellate record, this panel has determined
    unanimously to grant the parties’ request for a decision on the briefs without oral
    argument. See Fed. R. App. P. 34(f); 10th Cir. R. 34.1(G). The case is therefore
    ordered submitted without oral argument.
    *
    This order and judgment is not binding precedent, except under the
    doctrines of law of the case, res judicata, and collateral estoppel. The court
    generally disfavors the citation of orders and judgments; nevertheless, an order
    and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3.
    Petitioners Mid-Del Therapeutic Center, Inc. (Mid-Del) and D. Richard
    Ishmael, M.D., PC (PC), appeal the Tax Court’s denial of litigation costs after
    successfully contesting the Commissioner of the Internal Revenue Service’s
    (Commissioner) deficiency determinations in docket numbers 9060-97 and
    9270-97. Because we conclude the Tax Court did not abuse its discretion in
    determining that the position of the government at trial was substantially      justified,
    we affirm.
    I.
    The facts surrounding this dispute are well known to the parties and
    described at length in both the Tax Court’s Memorandum Findings of Fact and
    Opinion filed April 11, 2000, and its Memorandum Opinion filed December 19,
    2000. Dr. Ishmael owns both Mid-Del and PC, which operate medical clinics
    that purchase and use chemotherapy drugs to treat patients with cancer and
    other serious illnesses. Until 1983, both Mid-Del and PC used the cash method
    of accounting for tax purposes, reporting the drugs used in patient treatments
    as supplies and not inventory. That year, Mid-Del switched to the accrual
    method for its tax purposes.   1
    After being audited that year, Mid-Del was
    1
    Previously, Mid-Del had used the cash method of accounting for tax
    purposes, but the accrual method in its bookkeeping. Under the cash method of
    accounting, all items of gross income and expenditures for expenses are included
    in income or deducted in the taxable year in which they are actually received or
    (continued...)
    -2-
    required to return to use of the cash method and to pay a tax deficiency
    of $12,485.
    On April 23, 1997, the Commissioner determined that Mid-Del and PC
    were both required to use the accrual method of accounting in order to
    clearly reflect their income, and issued tax deficiencies of $140,025 for
    Mid-Del and $211,979 for PC.   2
    Mid-Del and PC separately petitioned the
    Tax Court, and the cases were consolidated for trial.
    1
    (...continued)
    made. Under the accrual method, income and deductions are included in the
    taxable year when (1) all of the events have occurred that fix the right to receive
    income or pay liability and the amount can be determined with reasonable
    accuracy; and (2) for, expenses, economic performance must have occurred during
    the taxable year. See Jacob Mertens, Jr., 2 Mertens Law of Federal Income
    Taxation § 12A (2001).
    2
    Section 446 of the Internal Revenue Code states:
    (a) General Rule.– Taxable income shall be computed under the
    method of accounting on the basis of which the taxpayer regularly
    computes his income in keeping his books.
    (b) Exceptions.– If no method of accounting has been regularly used
    by the taxpayer, or if the method used does not clearly reflect
    income, the computation of taxable income shall be made under such
    method as, in the opinion of the Secretary, does clearly reflect
    income.
    
    26 U.S.C. § 446
    (a), (b).
    -3-
    The primary arguments at that trial were summarized by the Tax Court
    as follows:
    By regulation, the Secretary has determined that inventories are
    necessary in every case in which the production, purchase, or sale of
    merchandise is an income-producing factor in the taxpayer’s
    business. See sec. 1.471-1, Income Tax Regs. Unless otherwise
    authorized by the Commissioner, a taxpayer who is required to
    maintain inventories must use an accrual method of accounting with
    regard to purchases and sales of inventory. . . .
    [The Commissioner] argues that the drugs at issue in
    this case are merchandise, the purchase and sale of which are
    income-producing factors in [Mid-Del and PC’s] businesses, and,
    therefore, [Mid-Del and PC] are required to use the accrual method
    of accounting to report their taxable income. [Mid-Del and PC] take
    exception to [the Commissioner’s] characterization of the drugs,
    countering that the drugs are supplies used in the course of treating
    patients, with the result that, under their view, the regulations
    requiring the use of the accrual method are inapplicable.
    R. Vol. I, Doc. 30 (
    T.C. Memo. 2000-130
    ) at 18-19 (further citations omitted).
    After the cases were tried, but before the opinion was issued, the Tax Court
    issued an opinion that decided “for the first time whether the furnishing of
    pharmaceuticals by a medical treatment facility as an integral, indispensable, and
    inseparable part of the rendering of medical services is the sale of ‘merchandise’
    for purposes of section 1.471-1, Income Tax Regs.”    Osteopathic Med. Oncology
    & Hematology, P.C. v. Comm’r,     
    113 T.C. 376
    , 380 (1999). In that case, the court
    held that the drugs at issue were not merchandise, and that the taxpayer, which
    specialized in treating cancer through chemotherapy, properly used the cash
    -4-
    method to expense the cost of its drugs and to report income. In the present case,
    the Tax Court relied heavily on its decision in   Osteopathic Med. and found, for
    the same reasons, that the drugs used by Mid-Del and PC were not merchandise
    and that, therefore, they were not required to maintain inventories or use the
    accrual method of accounting. The court found for Mid-Del and PC, and the
    tax assessments were ultimately abated.
    Mid-Del and PC subsequently filed for litigation costs pursuant to
    
    26 U.S.C. § 7430
    . The Tax Court denied that motion, finding the Commissioner’s
    position at trial, although unsuccessful, was substantially justified. This appeal
    followed.
    II.
    We review the Tax Court’s denial of litigation costs for an abuse of
    discretion.   Barford v. Comm’r, 
    194 F.3d 782
    , 786 (7th Cir. 1999);    see also Pate
    v. United States, 
    982 F.2d 457
    , 459 (10th Cir. 1993) (applying same standard to
    district court applying § 7430). In applying this deferential standard, we are
    reminded by the Supreme Court “that a request for attorney’s fees should not
    result in a second major litigation.”    Pierce v. Underwood,   
    487 U.S. 552
    , 563
    (1988) (quotation omitted). Section 7430 states in pertinent part that “[i]n
    any . . . court proceeding which is brought by or against the United States in
    connection with the determination, collection, or refund of any tax, interest or
    -5-
    penalty under [the Internal Revenue Code], the prevailing party may be
    awarded . . . reasonable litigation costs incurred in connection with such court
    proceeding.” 
    26 U.S.C. § 7430
    (a)(2). A prevailing party is one who has
    substantially prevailed in the amount in controversy or has substantially prevailed
    with respect to the most significant issue or set of issues presented. 
    26 U.S.C. § 7430
    (c)(4)(A). If the United States can establish that its litigating position was
    substantially justified, the petitioners will not qualify as prevailing parties.           
    Id.
    § 7430(c)(4)(B). Here, the parties agree that Mid-Del and PC substantially
    prevailed, and dispute only whether the government’s position was substantially
    justified.
    The term “substantially justified” means “justified to a degree that could
    satisfy a reasonable person” or having a “reasonable basis both in law and fact.”
    Pierce, 
    487 U.S. at 565
     (quotation omitted). In determining whether the position
    of the United States was substantially justified, “the court must look at all the
    facts and circumstances as well as relevant legal precedent.”          Anthony v. United
    States, 
    987 F.2d 670
    , 674 (10th Cir. 1993). The fact that the government loses
    the underlying litigation is not dispositive of the determination that its position
    was reasonable. Rather, “it remains a factor for our consideration.”               
    Id.
     ; see also
    Pierce, 
    487 U.S. at
    566 n.2 (“a position can be justified even though it is not
    correct, and we believe it can be substantially (     i.e., for the most part) justified if
    -6-
    a reasonable person could think it correct, that is, if it has a reasonable basis in
    law and fact”).
    Applying this test, we conclude the Tax Court did not abuse its discretion
    in finding the Commissioner was substantially justified in his litigation position.
    As that court noted, the Commissioner, relying on existing circuit and Tax Court
    precedent, argued reasonably that the drugs purchased and used by Mid-Del and
    PC were merchandise and an income-producing part of their business based on
    several factors tending to show that the drugs were no different from other
    tangible items held out for sale. It was only after the Tax Court issued
    Osteopathic Med., that it was clear that chemotherapy and other drugs, when used
    in the course of treating patients under certain circumstances, were inseparable
    and subordinate to the overall medical service such that they could not be
    considered held out for sale as merchandise. That opinion was one of first
    impression and became final only days before the Mid-Del-PC opinion was
    handed down. The facts as they were at the time of litigation, along with the
    applicable legal precedent as well as the discretionary authority traditionally
    granted the Commissioner, were sufficient for the Tax Court to conclude that the
    government’s position was justified to a degree that would satisfy a reasonable
    person.
    -7-
    III.
    On appeal, Mid-Del and PC present several arguments urging this court to
    find that the Tax Court abused its discretion in making its conclusion. However,
    we find these arguments to be unpersuasive. First, they argue that in order to
    decide whether the government’s litigation position was substantially justified,
    the Tax Court must review the substantive merits of the case. Taken to an
    extreme, this argument presumes that a determination that the government
    would fail on the merits would necessarily lead to an award of litigation costs,
    a presumption that we have already explained is incorrect.        See, e.g., Anthony ,
    
    987 F.2d at 674
    ; Graham v. United States (In re Graham),          
    981 F.2d 1135
    , 1139
    (10th Cir. 1992) (“[N]ot every losing party will have been substantially
    unjustified in its litigation position.”).   3
    Nevertheless, Mid-Del and PC argue
    3
    Related to this argument is Mid-Del and PC’s claim, argued more forcefully
    in their motion for award of litigation costs before the Tax Court, that a finding
    that the Commissioner abused his discretion or acted arbitrarily, capriciously, or
    without sound basis in fact or law, necessarily leads to an award of litigation
    costs. This claim can be alluring because a court’s finding that the government’s
    position was arbitrary and capricious may appear, at least on the surface, to be at
    odds with its subsequent determination that the government’s position was
    substantially justified. The opposite conclusion, however, is implicit in our cases
    cited previously (noting that the outcome in the underlying litigation is not
    dispositive of the question of litigation costs), and explicit in other cases in which
    reviewing courts use an abuse of discretion or similar standard to determine the
    merits of an issue but which, nonetheless, find that determination is not per se
    unreasonable. See, e.g., Fed. Election Comm’n v. Rose,     
    806 F.2d 1081
    , 1089
    (D.C. Cir. 1986) (explaining agency position may be substantially justified even
    (continued...)
    -8-
    that other substantive arguments, which were not addressed in the first opinion
    as being unnecessary in light of the Tax Court’s favorable decision on the
    drugs-as-merchandise issue, demonstrate that the Commissioner was not
    substantially justified in his litigating position. However, in its memorandum
    opinion, the Tax Court again found that the relevant facts and circumstances,
    coupled with the Commissioner’s legal theory and reliance upon applicable legal
    precedent, demonstrated substantial justification for his litigation position. Given
    our narrow standard of review, and after reading the record, we are persuaded that
    the Tax Court did not abuse its discretion in making this determination.
    Second, Mid-Del and PC argue that their notice of deficiency was based on
    inaccurate accruable income computations that substantially overstated their
    deficiency, and claim that these errors further demonstrate that the
    Commissioner’s litigation position was unjustified. Again, this argument
    attempts to collapse Congress’ distinction between the legal standard for litigation
    cost evaluations and the applicable standard to the underlying merits of their
    claim. We decline to ignore that distinction.
    3
    (...continued)
    if the action taken by the agency is deemed to be arbitrary and capricious);
    Abernathy v. Clarke, 
    857 F.2d 237
    , 239 (4th Cir. 1988) (rejecting argument that
    agency action reversed as arbitrary and capricious is, by definition, not
    substantially justified under 
    28 U.S.C. § 2412
    ); Nalle v. Comm’r, 
    55 F.3d 189
    ,
    194 (5th Cir. 1995) (rejecting the same argument under 
    26 U.S.C. § 7430
    ).
    -9-
    Finally, because Mid-Del was told in 1993 to return to the cash method of
    accounting, Mid-Del and PC now argue that we should invoke the doctrine of
    equitable estoppel to find that the Commissioner was barred from subsequently
    requiring them to switch to the accrual method. As noted by the Tax Court, the
    weight of authority on this issue favors the government.     See Auto. Club of Mich.
    v. Comm’r, 
    353 U.S. 180
    , 183 (1957) (“The doctrine of equitable estoppel is not
    a bar to the correction by the Commissioner of a mistake of law.”);       see also Ezo
    Prods. Co. v. Comm’r, 
    37 T.C. 385
    , 391 (1961);      Thomas v. Comm’r, 
    92 T.C. 206
    ,
    224-27 (1989). The government concedes that it made an error in 1993, and we
    understand the obvious distress that particular error has caused Mid-Del and PC
    over the years. However, we will not disturb the Tax Court’s ultimate finding in
    this case that the Commissioner’s litigating position was substantially justified.
    This court has carefully reviewed the remainder of Mid-Del and PC’s
    arguments on appeal and finds them to be without merit. The judgment of the
    Tax Court is AFFIRMED.
    Entered for the Court
    John C. Porfilio
    Circuit Judge
    -10-